Organic Active Ingredients TRIZ Cases

Lysine suppresses urushiol-induced dermatitis symptoms by competing with arginine uptake, preventing severe allergic inflammation.

Specific lipid mediator analogs mitigate cytokine storms and multi-organ failure in viral pneumonia.

Segmented 5-5 fused ring structures block C5a signaling to treat autoimmune diseases.

A duloxetine purification method uses pH adjustment to release the free base, followed by precipitation in methanol at low temperatures.

Bicyclic imidazo pyrimidone compounds inhibit Lp-PLA2 activity, reducing lysophosphatidylcholine production and inflammatory responses across disease stages.

Formula IV compound selectively inhibits SSAO/VAP-1 to reduce liver inflammation and fibrosis.

Administering citrulline addresses reduced nitric oxide availability to prevent vasospasm after aneurysmal subarachnoid hemorrhage.

Segmented multilayer tablets with bioadhesive polymers extend gastrointestinal residence time, improving drug bioavailability and reducing dosing frequency.

Adenosine base editors fuse deaminases with Cas9 nickase to convert adenine to guanine, reducing off-target modifications and indel formation.

A synthetic oligosaccharide composition containing LNFP III and LSTa regulates immune responses through targeted cytokine modulation.

Alternating electric fields disrupt mitosis in pluripotent stem cells, replacing complex antibody sorting and radiation with selective physical elimination.

Small molecule regulators modulate steroid receptor coactivator activity through targeted heterocyclic structures.

Hairpin oligonucleotides suppress miR-138 expression to eliminate resistant glioma stem cells and prevent tumor recurrence.

An HK2 depleting agent targets FGFR signaling to inhibit pathological angiogenesis without toxic side effects.

An oral pharmaceutical formulation combines denatonium salts with formoterol to deliver bronchodilation through systemic circulation.

DMG supplementation lowers ascites mortality by enhancing metabolic efficiency under high-calorie feeding.

BAP1 complex inhibition rescues aberrant gene expression patterns caused by ASXL1 gain-of-function mutations, delaying leukemia progression.

A Janus kinase inhibitor synthesis process uses safer reagents to generate crystalline intermediates.

Optimized tether length and hydrophobicity balance E3 ligase recruitment with specificity to degrade CDK4 and CDK6.

Composite lipid formulation with PEG-modified lipids prevents storage aggregation while maintaining cell membrane penetration efficiency.

A crystalline dimaleate salt of glasdegib improves dissolution rate and solubility through specific crystallization conditions.

Formula I and II compounds selectively inhibit cardiac late sodium current, reversing electrical abnormalities where existing inhibitors lack selectivity.

TRAIL compounds modulate TRAIL/DR5 signaling to reduce radiation-induced pneumonitis and fibrosis while maintaining cancer treatment efficacy.

A polymyxin B nonapeptide assay differentiates carbapenem-resistant bacteria by membrane impermeability.

Combining psilocybin with cannabinoids reduces symptom progression in brain disorders without side effects.

Thiouracil analogs inhibit Cyb5R3 to restore nitric oxide signaling, addressing insufficient inhibitor potency in hypertension treatment.

Periodic administration of a TEAD inhibitor on days 1 to 3 of each 7-day cycle reduces kidney toxicity while maintaining therapeutic efficacy.

Lipid-CSANs resolve the stability-reversibility trade-off by using host-guest chemistry for specific, trimethoprim-responsive disassembly.

Dasotraline oral dosage treats ADHD via slow dopamine transporter inhibition, avoiding rapid surges that cause abuse potential.

Merging MDM2-p53 inhibition with DNA hypomethylation via SGI-110 to selectively kill tumor cells while minimizing effects on normal tissue.

A topical spinosyn composition penetrates the stratum corneum to reduce mite populations without systemic absorption.

Ionizable lipid nanoparticles encapsulate therapeutic mRNA to enable efficient cellular uptake and transfection in fetal organs.

Deuterium-enriched nirmatrelvir eliminates ritonavir contraindications by improving metabolic stability without booster drugs.

Cyclodextrin inclusion complexes stabilize dantrolene at alkaline pH, resolving the contradiction between storage reliability and solution solubility.

A cytokine storm scoring algorithm integrates multiple biomarker levels to identify high-risk patients requiring targeted immunomodulation therapy.

Small molecule heterocycles block PD-1/PD-L1 binding, overcoming cancer evasion mechanisms that suppress immune responses.

Replacing chloride salts with sulfate electrolytes eliminates the salty taste that causes nausea while maintaining effective bowel evacuation.

Administers testosterone and progestin to lower breast cancer risk while avoiding menopausal symptoms caused by estrogen blockade.